Skip to content

Assessment of effectiveness of oral vitamin D3 on Bacterial vaginosis in women in fertility ages

Assessment of effectiveness of oral vitamin D3 on Bacterial vaginosis in women in fertility ages

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105096284N2
Enrollment
190
Registered
2011-09-04
Start date
2011-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial vaginosis. Acute vaginitis

Interventions

Intervention 1: Placebo drops of Sesame oil only, with the shape, taste, color & smell as same as intervention group which is prescribed 2 drops per day for 105 days. Intervention 2: Oral drops of vi
Placebo
Treatment - Drugs
Placebo drops of Sesame oil only, with the shape, taste, color & smell as same as intervention group which is prescribed 2 drops per day for 105 days
Oral drops of vitamin D3 which is prescribed Two drops (2000 IU vitamin D) per day for 105 days.

Sponsors

Vice chancellor for research, Tehran University of Medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Ages 18-35; Stability in medical condition among 6 months later; Lack of Pathological obesity; Not using tobacco; Lack of history of hypercalcemia, nephrolitiasis or sarcoidosis; Lack of current pregnancy; Lack of recent history of hospitalization; Absence of liver or kidney disorder; current malignancy or malabsorption; Lack of immune suppression, or those drugs that will interfere with vitamin D metabolism, such as phenytoin and carbamazepine; Not taking vitamin D supplements meet; Lack of clinical bacterial vaginosis; Lack of normal amounts of vitamin D in first assessment; Detection of asymptomatic bacterial vaginosis with nugent test Exclusion criteria: Unwillingness to continue the use of drug; pregnancy occurred; Drug allergy symptoms such as gastrointestinal symptoms; Vaginal infection symptoms like foul-smelling discharge; Use of drug non according to the pharmacist recommendation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bacterial vaginosis. Timepoint: 105 days. Method of measurement: Nugent test.

Secondary

MeasureTime frame
Concentration of vitamin D in serum. Timepoint: 105 days. Method of measurement: Lab test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masud Yunesian

Tehran University of Medical sciences

younesian@tums.ac.ir+98 21 8163 3619

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026